Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PBM fitness as vehicle for disease management initiatives remains open question, FTC official says.

Executive Summary

PBM FITNESS FOR DISEASE MANAGEMENT QUESTIONED BY FTC OFFICIAL at a Food & Drug Law Institute conference in Washington, D.C. Sept. 4. While disease management "seems like an initiative that pharmaceutical companies are very well suited for, the question we've always had and still have is whether [pharmacy benefit managers] are really the right vehicle" for the initiative, Federal Trade Commission Bureau of Competition Assistant Director Michael McNeely said.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030800

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel